Medline (Nasdaq:MDLN) has received a warning letter from the FDA related to NAMIC brand angiographic control syringes and manifolds.
The US Food and Drug Administration (FDA) has issued a warning letter to Purolea Cosmetics Lab for several violations of Good ...
The US Food and Drug Administration (FDA) has issued warning letters to several drug manufacturers and compounders for ...
The company removed the devices from the market in February following complaints of the syringes disconnecting from manifolds ...
After Medline pulled off a massive $6.26 billion IPO late last year, the company now finds itself facing serious concerns being leveled by the FDA. The company is a mammoth medical device distributor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results